Reirradiation with stereotactic body radiotherapy for primary or secondary lung malignancies: Tumor control probability and safety analyses-Reference-Cited by-同舟云学术

Reirradiation with stereotactic body radiotherapy for primary or secondary lung malignancies: Tumor control probability and safety analyses

Published:2023-10 Issue: Volume:187 Page:109817
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Wang Huan-Huan,Chen Yuan,Liu Xin,Zaorsky Nicholas G,Mani Kyle,Niu Zhi-Min,Zheng Bo-Yu,Zeng Hong-Yu,Yan Yuan-Yuan,Li Yan-Jin,He Yuan,Ji Chao-Zhi,Sun Bing-Sheng,Meng Mao-Bin

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference71 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Lung cancer LDCT screening and mortality reduction-evidence, pitfalls and future perspectives;Oudkerk;Nat Rev Clin Oncol,2021

3. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN Guidelines): non-small cell lung cancer. Version 1.2022. Accessed August 24, 2022. Available from: https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.

4. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomized trials;Chang;Lancet Oncol,2015

5. Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy;Klement;Radiother Oncol,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STRILL: Phase I Trial Evaluating Stereotactic Body Radiotherapy (SBRT) Dose Escalation for Re-Irradiation of Inoperable Peripheral Lung Lesions;Diseases;2024-07-12